Your request to link to rcsb for Stromelysin-1


  • 1CAQ: x-ray structure of human stromelysin catalytic domain complexes with non-peptide inhibitors: implication for inhibitor selectivity
  • 1CIZ: x-ray structure of human stromelysin catalytic domain complexes with non-peptide inhibitors: implication for inhibitor selectivity
  • 1CQR: crystal structure of the stromelysin catalytic domain at 2.0 a resolution (10.1006/JMBI.1999.3147 )
  • 1D5J: crystal structure of mmp3 complexed with a thiazepine based inhibitor. (10.1021/JM990330Y )
  • 1D7X: crystal structure of mmp3 complexed with a modified proline scaffold based inhibitor. (10.1021/JM9904699 )
  • 1D8F: crystal structure of mmp3 complexed with a piperazine based inhibitor. (10.1021/JM990366Q )
  • 1D8M: crystal structure of mmp3 complexed with a heterocycle- based inhibitor (10.1016/S0960-894X(01)00137-8 )
  • 1G05: heterocycle-based mmp inhibitor with p2'substituents (10.1016/S0960-894X(01)00137-8 )
  • 1G49: a carboxylic acid based inhibitor in complex with mmp3 (10.1021/JM000246E )
  • 1G4K: x-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin (10.1110/PS.48401 )
  • 1HFS: crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the n-carboxy-alkyl inhibitor l-764,004 (10.1021/JM960465T )
  • 1HY7: a carboxylic acid based inhibitor in complex with mmp3 (10.1021/JM000477L )
  • 1OO9: orientation in solution of mmp-3 catalytic domain and n- timp-1 from residual dipolar couplings (10.1021/BI034545S )
  • 1Q3A: crystal structure of the catalytic domain of human matrix metalloproteinase 10 (10.1016/J.JMB.2003.12.033 )
  • 1QIA: crystal structure of stromelysin catalytic domain
  • 1QIC: crystal structure of stromelysin catalytic domain
  • 1SLM: crystal structure of fibroblast stromelysin-1: the c-truncated human proenzyme
  • 1SLN: crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the n-carboxy-alkyl inhibitor l-702,842
  • 1UEA: mmp-3/timp-1 complex (10.1038/37995 )
  • 1UMS: stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% acetonitrile; nmr ensemble of 20 structures
  • 1UMT: stromelysin-1 catalytic domain with hydrophobic inhibitor bound, ph 7.0, 32oc, 20 mm cacl2, 15% acetonitrile; nmr average of 20 structures minimized with restraints
  • 1USN: crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-142372
  • 2D1O: stromelysin-1 (mmp-3) complexed to a hydroxamic acid inhibitor (10.1016/J.BBRC.2006.03.098 )
  • 2JNP: solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-isobutyl-n-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (nngh) (10.1007/S00775-007-0288-9 )
  • 2JT5: solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid (mlc88) (10.1007/S00775-007-0288-9 )
  • 2JT6: solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of 3-4'-cyanobyphenyl-4-yloxy)-n-hdydroxypropionamide (mmp-3 inhibitor vii) (10.1007/S00775-007-0288-9 )
  • 2SRT: catalytic domain of human stromelysin-1 at ph 5.5 and 40oc complexed with inhibitor (10.1038/NSB0294-111 )
  • 2USN: crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with thiadiazole inhibitor pnu-141803
  • 3OHL: catalytic domain of stromelysin-1 in complex with n-hydroxy-2-(4- methoxy-n-(pyridine-3-ylmethyl)phenylsulfonamido)acetamide
  • 3OHO: catalytic domain of stromelysin-1 in complex with n-hydroxy-2-(4- methylphenylsulfonamido)acetamide
  • 3USN: structure of the catalytic domain of human fibroblast stromelysin-1 inhibited with the thiadiazole inhibitor ipnu-107859, nmr, 1 structure
  • 3V96: complex of matrix metalloproteinase-10 catalytic domain (mmp-10cd) with tissue inhibitor of metalloproteinases-1 (timp-1) (10.1074/JBC.M112.341156 )
  • 4DPE: structure of mmp3 complexed with a platinum-based inhibitor. 27-feb-13 4dpe 1 title (10.1039/C3CC41278D )
  • 4G9L: structure of mmp3 complexed with nngh inhibitor. (10.1039/C3CC41278D )
  • 4ILW: complex of matrix metalloproteinase-10 catalytic domain (mmp-10cd) with tissue inhibitor of metalloproteinases-2 (timp-2) (10.1371/JOURNAL.PONE.0075836 )
  • 4JA1: structure of mmp3 complexed with a platinum-based inhibitor (10.1039/C3CC41278D )
  • 6MAV: complex of tissue inhibitor of metalloproteinase-1 (timp-1) mutant l34g with matrix metalloproteinase-3 catalytic domain (mmp-3cd) (10.1074/JBC.RA119.008321 )
  • 6N9D: complex of tissue inhibitor of metalloproteinases-1 (timp-1) mutant (l34g/l133p/l151c/g154a) with matrix metalloproteinase-3 catalytic domain (mmp-3cd) (10.1074/JBC.RA119.008321 )